influenza ha (307319)

Influenza Hemagglutinin is an HLA-DRB 0101-restricted epitope from influenza hemagglutinin (307-319).

Influenza HA (110-119) acetate is the 110-119 fragment of influenza virus hemagglutinin that can stimulate Treg cells proliferation[1][2].

Anti-Influenza HA Antibody (3E1) is an antibody. Its expression system is HEK293 cells, the clone number is 3E1, and the isotype control is IgG2, Kappa.

Influenza HA (126-138) is a peptide derived from the hemagglutinin (HA) protein of the influenza virus, consisting of amino acids 126-138, and has the ability to induce apoptosis in both thymic and peripheral T-cells.

Influenza HA (307-319) acetate is the 307-319 amino acid fragment of the influenza virus hemagglutinin (HA) protein, an HLA-DRB1 0101-restricted epitope polypeptide with the sequence PKYVKQNTLKLAT, which can be used for the study of influenza virus immunogenicity as well as for the development of vaccines and diagnostic reagents against influenza virus.

Anti-Influenza HA Antibody (CR6261) is an antibody. Its expression system is HEK293 cells, the clone number is CR6261.

Influenza HA (110-119) refers to a specific fragment (110-119) derived from the hemagglutinin protein of the influenza virus. This fragment has the ability to induce the proliferation of Treg cells.

Influenza HA (518-526) is an H-2d-restricted CD8+ T cell epitope derived from the influenza virus hemagglutinin. This sequence is highly conserved across multiple H5N1, some H9N2, and certain H1N1 strains. The epitope can bind to the mouse MHC class I allele Kd to form a complex, which is subsequently recognized by specific CD8+ T lymphocytes. In influenza-infected BALB/c mice, Influenza HA (518-526) represents an immunodominant epitope that stimulates CD8+ T cells to release IFN-γ, thereby inducing a robust immune response. Currently, this epitope has been widely applied in research related to respiratory syncytial virus (RSV), influenza virus, and H5N1 influenza, among other fields.